Status:
RECRUITING
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
The University of Texas Health Science Center, Houston
University of South Carolina
Conditions:
Nicotine Vaping
Nicotine Use Disorder
Eligibility:
All Genders
15-25 years
Phase:
PHASE1
Brief Summary
Use of vaping products (e.g., electronic nicotine delivery systems, e-cigarettes) has been increasing rapidly, particularly among teens and young adults. With limited information on the long-term effe...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- US Resident
- English Speaking
- Have daily access to a smartphone
- Current vaping product user (P30D)
- Identified as socially networking about a desire to quit vaping and/or experiencing negative health outcomes due to vaping
- Vaping product user only (i.e., not using vaping as a means to support combustible smoking cessation)
Exclusion
Key Trial Info
Start Date :
June 4 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
189 Patients enrolled
Trial Details
Trial ID
NCT05994209
Start Date
June 4 2025
End Date
June 1 2026
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University in St. Louis, School of Medicine
St Louis, Missouri, United States, 63110